We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

COVID-19 Response

COVID-19 Response

Read about how we are actively responding to the global COVID-19 pandemic.

© 2022 Genentech, Inc. All rights reserved. This site is intended for US residents only.